Related references
Note: Only part of the references are listed.Detection of myositis-specific antibodies
Jean-Baptiste Vulsteke et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Comparison of autoantibody specificities tested by a line blot assay and immunoprecipitation-based algorithm in patients with idiopathic inflammatory myopathies
Fabricio Espinosa-Ortega et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis
Audrey Aussy et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups
Simon Rothwell et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
The temporal relationship between cancer and adult onset anti-transcriptional intermediary factor 1 antibody-positive dermatomyositis
Alexander Oldroyd et al.
RHEUMATOLOGY (2019)
Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis
Iago Pinal-Fernandez et al.
RHEUMATOLOGY (2018)
Autoantibodies in myositis
Neil J. McHugh et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies
Kuberaka Mariampillai et al.
JAMA NEUROLOGY (2018)
Genetic background may contribute to the latitude-dependent prevalence of dermatomyositis and anti-TIF1-γ autoantibodies in adult patients with myositis
Joanna E. Parkes et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Increasing incidence of adult idiopathic inflammatory myopathies in the City of Salford, UK: a 10-year epidemiological study
Matthew J. S. Parker et al.
RHEUMATOLOGY ADVANCES IN PRACTICE (2018)
The Immune Response and the Pathogenesis of Idiopathic Inflammatory Myositis: a Critical Review
Angela Ceribelli et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2017)
Macrophage production and activation are dependent on TRIM33
Anne-Sophie Gallouet et al.
ONCOTARGET (2017)
TRIM33 is essential for osteoblast proliferation and differentiation via BMP pathway
Jia Guo et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients
Jemima Albayda et al.
ARTHRITIS CARE & RESEARCH (2017)
A New Classification of Adult Autoimmune Myositis
Jean-Luc Senecal et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Dermatomyositis and immune-Mediated Necrotizing Myopathies: A window on Autoimmunity and Cancer
Audrey Aussy et al.
FRONTIERS IN IMMUNOLOGY (2017)
2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups
Ingrid E. Lundberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study
Hanbo Yang et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Expression of the autoantigen TRIM33/TIF1γ in skin and muscle of patients with dermatomyositis is upregulated, together with markers of cellular stress
B. Scholtissek et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2017)
Repression of TIFγ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer
L. Wang et al.
ONCOGENE (2016)
High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody
Yves Allenbach et al.
BRAIN (2016)
Recent advances in dermatomyositis-specific autoantibodies
Manabu Fujimoto et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
Trim33/Tif1γ is involved in late stages of granulomonopoiesis in mice
Marie-Lorraine Chretien et al.
EXPERIMENTAL HEMATOLOGY (2016)
A Novel Role of Chromodomain Protein CBX8 in DNA Damage Response
Jay Oza et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis
Manabu Fujimoto et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2016)
Testing for myositis specific autoantibodies: Comparison between line blot and immunoprecipitation assays in 57 myositis sera
Ilaria Cavazzana et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2016)
Anti-TIF1-γ antibody and cancer-associated myositis A clinicohistopathologic study
Ayumi Hida et al.
NEUROLOGY (2016)
SnoN suppresses TGF--induced epithelial-mesenchymal transition and invasion of bladder cancer in a TIF1-dependent manner
Xinbao Yin et al.
ONCOLOGY REPORTS (2016)
Ovoid Palatal Patch in Dermatomyositis: A Novel Finding Associated With Anti-TIF1γ (p155) Antibodies
Laura L. Bernet et al.
JAMA DERMATOLOGY (2016)
TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients
Loay Kassem et al.
BMC CANCER (2015)
TIF1γ Suppresses Tumor Progression by Regulating Mitotic Checkpoints and Chromosomal Stability
Roxane M. Pommier et al.
CANCER RESEARCH (2015)
Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets
Syed A. Haq et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2015)
Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis
David F. Fiorentino et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
High incidence of cancer in anti-small ubiquitin-like modifier activating enzyme antibody-positive dermatomyositis
Yoshinao Muro et al.
RHEUMATOLOGY (2015)
TRIM33 switches off Ifnb1 gene transcription during the late phase of macrophage activation
Federica Ferri et al.
NATURE COMMUNICATIONS (2015)
Tumour suppressor TRIM33 targets nuclear β-catenin degradation
Jianfei Xue et al.
NATURE COMMUNICATIONS (2015)
Polymyositis/dermatomyositis and Malignancy Risk: A Metaanalysis Study
Zaixing Yang et al.
JOURNAL OF RHEUMATOLOGY (2015)
miR-629 Targets TRIM33 to Promote TGF beta/Smad Signaling and Metastatic Phenotypes in ccRCC
Kentaro Jingushi et al.
MOLECULAR CANCER RESEARCH (2015)
Incidence and prevalence of inflammatory myopathies: a systematic review
Alain Meyer et al.
RHEUMATOLOGY (2015)
Expression of the Dermatomyositis Autoantigen Transcription Intermediary Factor 1γ in Regenerating Muscle
Payam Mohassel et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Reduced Expression of Transcriptional Intermediary Factor 1 Gamma Promotes Metastasis and Indicates Poor Prognosis of Hepatocellular Carcinoma
Ze-yang Ding et al.
HEPATOLOGY (2014)
The E3 Ubiquitin Ligase Tripartite Motif 33 Is Essential for Cytosolic RNA-Induced NLRP3 Inflammasome Activation
Leiyun Weng et al.
JOURNAL OF IMMUNOLOGY (2014)
Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP-2 or Transcription Intermediary Factor 1γ
David F. Fiorentino et al.
ARTHRITIS AND RHEUMATISM (2013)
Meta-analysis of the association of dermatomyositis and polymyositis with cancer
J. Wang et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Tif1γ is essential for the terminal differentiation of mammary alveolar epithelial cells and for lactation through SMAD4 inhibition
Cedric Hesling et al.
DEVELOPMENT (2013)
Tripartite Motif-containing 33 (TRIM33) Protein Functions in the Poly(ADP-ribose) Polymerase (PARP)-dependent DNA Damage Response through Interaction with Amplified in Liver Cancer 1 (ALC1) Protein
Atul Kulkarni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
TIF1γ requires sumoylation to exert its repressive activity on TGFβ signaling
Laurent Fattet et al.
JOURNAL OF CELL SCIENCE (2013)
A critical role for immature muscle precursors in myositis
Anne Tournadre et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Transcriptional intermediary factor 1γ binds to the anaphase-promoting complex/cyclosome and promotes mitosis
G. G. Sedgwick et al.
ONCOGENE (2013)
Response to Cabozantinib in Patients with RET Fusion-Positive Lung Adenocarcinomas
Alexander Drilon et al.
CANCER DISCOVERY (2013)
Autoantibodies in Polymyositis and Dermatomyositis
Anna Ghirardello et al.
CURRENT RHEUMATOLOGY REPORTS (2013)
Tif1 γ Suppresses Murine Pancreatic Tumoral Transformation by a Smad4-Independent Pathway
David F. Vincent et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays
Moises Labrador-Horrillo et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Autoantibodies to transcription intermediary factor 1 in dermatomyositis shed insight into the cancer-myositis connection
David Fiorentino et al.
ARTHRITIS AND RHEUMATISM (2012)
Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: A systematic review and meta-analysis
Ernesto Trallero-Araguas et al.
ARTHRITIS AND RHEUMATISM (2012)
Regulation of TGF-β signal transduction by mono- and deubiquitylation of Smads
Sirio Dupont et al.
FEBS LETTERS (2012)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
Dynamic Regulation of Tgf-B Signaling by Tif1γ: A Computational Approach
Geoffroy Andrieux et al.
PLOS ONE (2012)
Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells
Cedric Hesling et al.
EMBO REPORTS (2011)
Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia
Romain Aucagne et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Recruitment of TIF1γ to Chromatin via Its PHD Finger-Bromodomain Activates Its Ubiquitin Ligase and Transcriptional Repressor Activities
Eleonora Agricola et al.
MOLECULAR CELL (2011)
Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis
Andrew L. Mammen
NATURE REVIEWS NEUROLOGY (2011)
Association of overexpression of TIF1γ with colorectal carcinogenesis and advanced colorectal adenocarcinoma
Shilpa Jain et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Novel autoantibodies and clinical phenotypes in adult and juvenile myositis
Zoe E. Betteridge et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Malignancy in Myositis
Zaki Abou Zahr et al.
CURRENT RHEUMATOLOGY REPORTS (2011)
Malignancy and myositis: novel autoantibodies and new insights
Albert Selva-O'Callaghan et al.
CURRENT OPINION IN RHEUMATOLOGY (2010)
Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan
Yi-Ju Chen et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Inactivation of TIF1γ Cooperates with KrasG12D to Induce Cystic Tumors of the Pancreas
David F. Vincent et al.
PLOS GENETICS (2009)
Mechanisms of Disease: autoantigens as clues to the pathogenesis of myositis
Tomeka L. Suber et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2008)
The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis
Hector Chinoy et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Long-term outcome in polymyositis and dermatomyositis
I. M. Bronner et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
A novel autoantibody to a 155-kd protein is associated with dermatomyositis
Ira N. Targoff et al.
ARTHRITIS AND RHEUMATISM (2006)
Hematopoiesis controlled by distinct TIF1γ and Smad4 branches of the TGFβ pathway
Wei He et al.
CELL (2006)
Germ-layer specification and control of cell growth by ectodermin, a Smad4 ubiquitin ligase
S Dupont et al.
CELL (2005)
Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathy
L Casciola-Rosen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study
CL Hill et al.
LANCET (2001)
Share Paper
